- Home
- BCRX vs STRA Comparison
BCRX vs STRA Comparison
Compare BCRX & STRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- STRA
- Stock Information
- Founded
- BCRX 1986
- STRA 2017
- Country
- BCRX United States
- STRA United States
- Employees
- BCRX N/A
- STRA N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- STRA Other Consumer Services
- Sector
- BCRX Health Care
- STRA Real Estate
- Exchange
- BCRX Nasdaq
- STRA Nasdaq
- Market Cap
- BCRX 1.7B
- STRA 2.0B
- IPO Year
- BCRX 1994
- STRA 1996
- Fundamental
- Price
- BCRX $9.97
- STRA $89.26
- Analyst Decision
- BCRX Buy
- STRA
- Analyst Count
- BCRX 8
- STRA 0
- Target Price
- BCRX $16.75
- STRA N/A
- AVG Volume (30 Days)
- BCRX 5.9M
- STRA 227.0K
- Earning Date
- BCRX 05-05-2025
- STRA 04-24-2025
- Dividend Yield
- BCRX N/A
- STRA 2.72%
- EPS Growth
- BCRX N/A
- STRA 11.28
- EPS
- BCRX N/A
- STRA 4.68
- Revenue
- BCRX $503,485,000.00
- STRA $1,233,270,000.00
- Revenue This Year
- BCRX $27.64
- STRA $6.07
- Revenue Next Year
- BCRX $13.42
- STRA $5.18
- P/E Ratio
- BCRX N/A
- STRA $18.85
- Revenue Growth
- BCRX 41.67
- STRA 5.72
- 52 Week Low
- BCRX $5.06
- STRA $74.28
- 52 Week High
- BCRX $11.11
- STRA $123.41
- Technical
- Relative Strength Index (RSI)
- BCRX 65.89
- STRA 68.16
- Support Level
- BCRX $9.83
- STRA $87.76
- Resistance Level
- BCRX $11.11
- STRA $89.94
- Average True Range (ATR)
- BCRX 0.51
- STRA 2.58
- MACD
- BCRX 0.20
- STRA 1.19
- Stochastic Oscillator
- BCRX 68.33
- STRA 94.68
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About STRA Strategic Education Inc.
Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.